TA Associates Announces Strategic Growth Investment in Adcubum and tech11 to Create Leading Health and P&C Insurance Software Provider in Europe
Nordic-based life sciences venture capital investor Eir Ventures Partners has held a final close for its fund Eir Ventures I on EUR 122.3m.
Triton has made a GBP 1.2bn take-private offer for UK-based listed pharmaceutical services and products provider Clinigen; the company's board has agreed to the offer, according to a statement.
Healthcare investor OrbiMed has promoted Matthew Rizzo and Peter Thompson as general partners. The post OrbiMed promoted Matthew Rizzo, Peter Thompson as general partners first appeared on AltAssets Private Equity News.
European private equity house Triton has agreed a £1.2bn take private deal with UK pharmaceutical firm Clinigen. The post Triton to take UK pharmaceutical firm Clinigen private in a £1.2bn deal first appeared on AltAssets
Health technology investor MTIP has held a USD 250m for MTIP Fund II.
Swiss healthtech-focused private equity firm MITP has hit a $250m final close for its oversubscribed second fundraise. The post MITP beats target with $250m final close of second Europe-focused healthtech fund first appeared on AltAssets
Global investment major KKR has hired Mukul Chawla from Temasek as partner and the newly-created head of growth equity in Asia Pacific. Chawla will lead the firm's regional investment strategy into emerging, high-growth companies in
Veritas Capital has followed its $17bn sale of athenahealth by agreeing to pick up school website and digital comms tools business Finalsite. The post Veritas Capital follows $17bn athenahealth sale with Finalsite buyout from Bridge
Bioscience and life sciences investor NovaQuest Capital Management has bought TechAccel's stake in Covenant Animal Health Partners. The post NovaQuest Capital picks up TechAccel stake in Covenant Animal Health Partners first appeared on AltAssets Private
Jeito Capital, Ridgeback Capital Investments, SV Health Investors and Fidelity Management & Research Company have led a USD 156m Series B funding round for biotechnology business Quell Therapeutics.
Chinese private equity and venture capital major Legend Capital has reportedly hit a $177m first close for its latest US-dollar denominated healthcare fund. The post China’s Legend past halfway for $300m-targeting US-dollar healthcare fund –
Cancer-fighting AI developer Lunit has picked up a $61m pre-IPO financing round from investors including HealthQuest Capital and Casdin Capital. The post Anti-cancer AI tools developer Lunit gets $61m pre-IPO funding round first appeared on AltAssets
